Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Fortress Biotech, Inc. (FBIO) had Income from Continuous Operations of $-11.65M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$16.41M |
|
$13.36M |
|
$4.94M |
|
$11.47M |
|
$52.89M |
|
$-36.47M |
|
$24.82M |
|
$-11.65M |
|
$-11.65M |
|
$-11.65M |
|
|
Income from Continuous Operations |
$-11.65M |
$-11.65M |
|
$-11.65M |
|
$-36.47M |
|
$-34.38M |
|
26.88M |
|
29.82M |
|
$0.50 |
|
$0.45 |
|
| Balance Sheet Financials | |
$110.40M |
|
$2.70M |
|
$49.50M |
|
$159.90M |
|
$57.52M |
|
$50.03M |
|
$64.99M |
|
$122.51M |
|
$37.38M |
|
$7.65M |
|
$37.38M |
|
29.75M |
|
| Cash Flow Statement Financials | |
$-47.12M |
|
$7.25M |
|
$56.66M |
|
$58.81M |
|
$75.61M |
|
$16.79M |
|
$23.08M |
|
$-0.33M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.92 |
|
-- |
|
-- |
|
0.57 |
|
1.44 |
|
69.91% |
|
-222.22% |
|
-222.22% |
|
-- |
|
-71.00% |
|
81.37% |
|
$-45.96M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.38 |
|
1.01 |
|
88.84 |
|
-31.18% |
|
-152.36% |
|
-7.29% |
|
-13.33% |
|
$1.26 |
|
$-1.54 |
|
$-1.58 |
|